CDKN2A and astrocytoma (excluding glioblastoma): Interestingly, two CNS WHO grade 4 astrocytomas harboring CDKN2A/B homozygous deletions were classified with the lower-grade astrocytoma subclass by methylation profiling, although one of the samples received a low classification score (< 0.90).